Edit |   |
---|---|
Antigenic Specificity | CD274, Human (Atezolizumab biosimilar) |
Clone | Atezolizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD274 Recombinant Antibody (Atezolizumab). Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), small cell lung cancer (SCLC), and hepatocellular carcinoma (HCC). It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). |
Immunogen | n/a |
Other Names | Anti-CD274 Recombinant Antibody, Research Grade Atezolizumab, Anti-Human CD274 Recombinant Antibody(Atezolizumab), MPDL3280A, RG7446, Antibody Drug Analogues, Monoclonal Antibody, YR1354, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1380723-44-3 |
Catalog # | YR1354 |
Price | please inquire |
Order / More Info | CD274, Human (Atezolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |